Viking Therapeutics Inc (NAS:VKTX)
$ 42.35 0.03 (0.07%) Market Cap: 4.72 Bil Enterprise Value: 3.79 Bil PE Ratio: 0 PB Ratio: 5.18 GF Score: 37/100

Q2 2023 Viking Therapeutics Inc Earnings Call Transcript

Jul 26, 2023 / 08:30PM GMT
Release Date Price: $14.28 (-1.45%)
Operator

Welcome to the Viking Therapeutics Second Quarter 2023 Financial Results Conference Call. (Operator Instructions)

I would now like to turn the conference over to Viking's Manager of Investor Relations, Stephanie Diaz. Please go ahead, Stephanie.

Stephanie C. Diaz
Vida Strategic Partners Inc. - President & CEO

Hello and thank you all for participating in today's call. Joining me today is Brian Lian, Viking's President and CEO; and Greg Zante, Viking's CFO.

Before we begin, I'd like to caution that comments made during this conference call today, July 26, 2023, will contain forward-looking statements under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements about Viking's expectations regarding its development activities, time lines and milestones. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and adversely and reported results should not be considered as an indication of future performance. These forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot